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1. Introduction 
1.1. Lactic acid bacteria 
 
Lactic acid bacteria (LAB) belong basically to the order Lactobacillales.  The genera 
harboring LAB comprise Lactobacillus, Lactococcus, Enterococcus, Bifidobacterium, 
Leuconostoc, Streptococcus, Pediococcus, Lactosphaera, Bacillus, Halolactobacillus, 
Carnobacterium, Vagococcus and many more. Lactic acid bacteria constitute a 
heterogenous group founded on metabolic characteristics, including temperature 
range of growth and agglutination, fermentation profiles and metabolic pathways. 
Nowadays identification of LAB species is often based on 16S RNA sequencing 
which is not sufficient to yield a reliable and proper result. Trustworthy classification 
has to be based on both genotypic and phenotypic methods. (Pot and Tsakalidou, 
2009) In accordance, Rossella-Mora and Amann (2001) claim that besides genetic 
evidence, phenotypic properties are required to discriminate a species from its 
closest phylogenetic neighbour. 
Traditionally LAB are grouped into obligatory homofermentative, facultatively 
heterofermentative and obligatory heterofermentative bacteria. They are usually 
catalase-negative, non-motile and non-spore forming cocci, coccobacilli or rods. All 
LAB are defined by the ability to produce considerable amounts of lactic acid as a 
major end product of carbohydrate metabolism. Lactic acid bacteria are also gram-
positive and acid-tolerant; they range from aero-tolerant to anaerobic and have in 
general a low GC-content. By acidifying their medium, they inhibit growth of other 
bacteria, which is a desirable feature used in food preservation. (Hammes and Vogel, 
1995) 
Representatives are usually found in nutrient-rich environments - soil, sewage, 
silage, the human oral cavity, the intestinal tract, the vagina and many more habitats 
rich in food substrates or plant materials - basing their metabolism on complex 
nutrients. Especially industrial lactobacilli used for decades for milk or meat 
fermentation are often referred to as “being crippled in metabolism”. Due to their 
limited biosynthetic capacity they require vitamins (folic acid, vitamin B12, pathotenic 
acid and more), amino acids, salts, fatty acid esters and nucleic acid derivatives for 
growth (Kandler, 1986). There are exceptions like L. plantarum which is able to 
prosper in a variety of niches and will be described later in more detail. 
2 
 
LAB are used in food- and feed-fermentations, like production of vegetable, 
meat and dairy products, but also play a significant role in preservation of ensiled 
forages. Commercial starter-cultures are available to ensure steady and reproducible 
acidity, flavour, texture and colour of the end-product or to prevent uncontrolled 
fermentation processes. They are not only used for acidification and fermentation of 
sugars or flavour compounds, but also for their proteolytic and lipolytic activities. 
Products of citrate fermentation influence aroma and quality of fermented goods (Pot 
and Tsakalidou, 2009). 
 
1.1.1. LAB used in the study 
1.1.1.1. L. plantarum 
 
Lactobacillus plantarum is a facultatively heterofermentative bacterium that produces 
DL-lactate, and contains meso-diaminopimelic acid in its cell wall. It is closely related 
to L. paraplantarum, L. pentosus, and L. arizonensis and cannot be distinguished 
from these species by 16S rRNA sequencing only (Hammes and Hertel, 2003). 
Molecular techniques to reliably identify L. plantarum are at hand, but often 
neglected, which might result in industrial products – like probiotics - with false 
descriptions. This problem is not exclusive to L. plantarum as will be discussed later. 
L. plantarum is encountered in many niches like dairy, meat, and vegetable or 
plant fermentations, including corn and grass silages. It was initially claimed to be a 
natural inhabitant of the human gastrointestinal tract and therefore found its way in 
probiotic products. The genome sequence of L. plantarum is known and one of the 
largest, providing a basis for its broad metabolic capacity. In effect, the strain WCFS1 
was sequenced and thoroughly tested. It was found to have a high number of sugar 
import systems and the capacity to use a large variety of carbon sources which 
affirms the high versatility and ecological flexibility of the species. It also displays a 
considerable number of genes coding for surface-anchored proteins which enables 
the strain to potentially bind a high number of substrates or surfaces. (Kleerebezem 
et al., 2003) 
In addition, L. plantarum has a repertoire of stress response systems, namely 
a heat-shock response, a cold-shock response, an acid-stress system, alkaline-
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shock proteins, oxidative stress-related proteins, and osmoprotection, which 
enhances its ability to thrive in different environments (Tamime, 2005). 
1.1.1.2. L. buchneri 
 
Lactobacillus buchneri is commonly used in corn and grass silages (Driehuis et al., 
1999; Li and Nishino, 2011). It increases stability of silages against yeast and moulds 
when exposed to air mainly by driving acetic acid production (Driehuis et al., 2001; 
Holzer et al., 2003). This is due to its ability to produce 1,2- and 1,3-propanediol from 
glycerol while metabolizing glucose or fructose. The co-fermentation results 
eventually in re-oxidation of the originally produced lactate to acetate which is 
deterrent to a number of other microorganisms. (Cunha and Foster, 1992) 
The heterofermentative bacterium contains lysine-D-asparagine in its cell wall 
(Pot and Tsakalidou, 2009). 
1.1.1.3. L. reuteri 
 
A particularly important strain in probiotics and this present work is Lactobacillus 
reuteri, a heterofermentative lactobacillum that is used in animal nutrition, yoghurt 
products and pharmaceutical preparations. L. reuteri can also be found in sourdough 
populations (Dal Bello et al., 2005).  
It is characterized by the ability to produce a bacteriocin called reuterin and 
therefore has the potential to inhibit growth of pathogenic bacteria like E.coli and L. 
monocytogenes (Klein et al., 1998; El-Ziney and Debevere, 1998). Furthermore, it 
has been identified as an indigenous inhabitant of the gastrointestinal tract of human, 
pig and chicken exhibiting tolerance to bile salts and acid as well as adhesion to the 
intestinal epithelium (Liu et al., 2005). There is significant effort to exploit production 
of galacto-oligosaccharides (GOS) by L. reuteri for pre- and synbiotic products 
(Splechtna et al., 2006). As will be described later in more detail ß-galactosidases 
are able to catalyze transgalactosylation reactions resulting in GOS which have a 
benficial influence on the intestinal probiotic microflora. 
Orally administered L. reuteri has also been found to exhibit immunoadjuvant 
activity by increasing expression of inflammatory cytokines and could therefore be 
used as a potential delivery vector for therapeutic proteins (Maassen et al., 2000). 
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1.1.1.4. E. faecium 
 
The facultatively anaerobic and coccoid Enterococcus faecium occurs chiefly in pairs 
or short chains, the peptidoglycan type is Lys-D-Asp (Schleifer and Klipper-Bälz, 
1984). 
Strains of enterococci are regularly used in animal nutrition, mainly pig and 
poultry. For instance, Enterococcus faecium is a common animal probiotic. It is also 
often isolated from clinical material known to cause nosocomial infections in 
immunocompromised hosts. (Klein et al., 1998) 
E. faecium are also commonly used in corn and grass silages (Driehuis et al., 
1999; Li and Nishino, 2011). 
 
1.1.1.5. L. lactis 
 
Lactococcus lactis is used as a dairy starter culture, and has more recently been 
studied as a live vehicle for the production of therapeutic molecules (Bahey-El-Din 
and Gahan, 2010). It is known to produce significant amounts of lactic acid via 
homolactic fermentation and small amounts of flavour compounds (Tamime, 2005). It 
is able to pass the gastrointestinal tract of mice, but is not able to establish as a 
natural inhabitant (Hiromi et al., 2003). 
The first strain to be sequenced was IL1403 (Bolotin et al., 2005) which was 
obtained by plasmid-curing. It was found that many traits were actually encoded by 
plasmids including genes for lactose metabolism and degradation of casein. It was 
also hypothesized that the strain as having a long history in dairy production had lost 
several biosynthetic capabilities compared to strains prospering in plant or animal 
environments. (Tamime, 2005) 
 
1.2. Probiotics 
 
Lactic acid bacteria are traditionally used in food industry and silage, but since the 
1990s their scope of applications includes a new field, namely probiotics. 
In 2002, Holzapfel and Schillinger defined probiotics as a term referring to 
“viable organisms that promote or support a beneficial balance of the autochthonous 
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microbial population of the gastrointestinal tract”. A more general definition was given 
by Tannock (2002) and Guarner et al (1998) who spoke of “living microorganisms, 
which upon ingestion in certain numbers, exert health benefits beyond inherent basic 
nutrition”.  
In either case it is crucial to understand the composition and characteristics of 
the enteric microflora. The mucosal surface of the gastrointestinal tract is sterile in 
the case of new-borns, but is quickly colonized by numerous genera. Depending on 
diet, medication, stress, age, genetic background and physiological state of the host, 
the exact composition of bacteria will be unique for each human (Tannock, 1997). 
Furthermore, the gastrointestinal tract (GIT) itself constitutes a spatially 
heterogeneous environment. The stomach and the first two-third of the small bowel 
are difficult to colonize due to the highly acidic pH of the stomach (up to pH 2) and 
toxic bile salts (Tannock, 1995). Hence, nutrient availability decreases in distal sites 
while bacterial numbers increase. Unique ecological niches are generated which 
eventually – according to the niche exclusion theory – support only one type of well-
adapted microbe each (Hardin, 1960). Allochthonous bacteria, introduced by food or 
residing in the oral cavity, will therefore face competitive exclusion as they pass the 
gastrointestinal tract that is already occupied by autochthonous bacteria or true 
residents. 
According to Gibson (1995) and Rastall (2004), the enteric microflora is 
dominated by strict anaerobes, like clostridia, peptococci, Bacteroides spp., 
Bifidobacterium spp. and Atopobium spp.. Studies using anaerobic culturing 
techniques (Dal Bello et al, 2003) and culture-independent fluorescent in situ 
hybridization (Harmsen et al., 2002) as well as GIT biopsy samples (Eckburg et al., 
2005) suggest that only few Lactobacillus species inhabit the human gastrointestinal 
tract and are more commonly present as allochthonous members. In 2001, Reuter 
identified L. ruminis, L. reuteri and L. gasseri as the only true autochthonous 
lactobacilli of the human gastrointestinal tract. 
Several aero-tolerant lactobacilli are currently used in a considerable number of 
probiotic products, as they are well known and easy to handle based on a long 
history of food fermentation.  In addition, they are thought to exert health benefits by 
antioxidant activity, production of bacteriocins that are active against pathogens, 
suppression of H. pylori colonization and infection, reduction of antibiotic associated 
colitis, and production of anti-mutagens and binding of mutagens (Ljungh and 
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Wadstrom, 2006). Also alleviation of lactose intolerance and cholesterol lowering 
effects have been linked to probiotics (Holzapfel and Schillinger, 2002). 
The putative ability to modulate the gastrointestinal flora and beneficially influence 
health has led to a huge economic interest in probiotic strains, favouring lactobacilli 
that can be handled and produced industrially in an easy way (O‟Sullivan et al.,1992; 
usprobiotics.org). 
However, most of these strains have been shown to be autochthonous to the 
human oral cavity, but only transient passengers to the GIT (Kimura et al., 1997).  
Reuter (2001) also claimed that “descriptions of strains used by producers of 
probiotic cultures are often incomplete or even false”. He criticizes industrial 
mismanagement which results in random selection of strains, unviable probiotics and 
deception of consumers. Persistence of lactobacilli in the GIT after oral 
administration has ceased also remains questionable when transient strains are 
used. Nonetheless, colonization might not be essential for a successful probiotic. 
Allochthonous strains might as well act by stimulating the immune system. Even 
dead cells were reported to exhibit beneficial immunological effects (Mottet and 
Michetti, 2005). 
Classification of autochthonous lactobacilli was also performed in pigs, chicken 
and rodents. These animal species display large numbers of truly inhabitant 
lactobacilli in the proximal gut. Their stomachs are mainly characterized by non-
secretory epithelium which enables adherence of lactobacilli and formation of biofilms 
accomplished by production of extracellular polymeric substances. (Tannock, 1992)  
Such stratified squamous epithelia are not present in the human gut, but in the oral 
cavity and vagina, habitats with high numbers of lactobacilli (Walter, 2008). 
In 2002, Leser et al. identified L. reuteri as an autochthonous member of the 
rodent and porcine gut. Further studies examined crucial proteins generated by L. 
reuteri that enable adherence to the gastrointestinal epithelium, cell aggregation, 
formation of biofilms and resistance to low pH values in mice, prerequisites for the 
existence of stable populations (Walter et al., 2008). L. reuteri was also shown to 
prevent colitis in immunodeficient mice (Madsen et al., 1999).  
In human studies, L. reuteri was shown to suppress H. pylori infections and to 
ameliorate acute diarrhoea in young children (Shornikova et al., 1997; Imase et al., 
2007). Various human isolates were shown to produce reuterin, an antimicrobial 
compound that is thought to model and shape the composition and spatial 
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architecture of the gastrointestinal microbiota (Jones and Versalovic, 2009). 
Furthermore, it is interesting to note, that L. reuteri strains in this study could be 
divided into immunosuppressive and immunostimulatory strains. Product description 
on species level does not offer sufficient information on origin, autochthony and 
suitability as a probiotic. 
Once again it has to be pointed out that effectiveness of probiotics is always 
strain-specific. Each strain has to be examined on its own to prove beneficial effects 
and to understand the underlying mechanisms. 
1.3. Prebiotics and synbiotics 
 
Prebiotics are growth-promoting substrates, mainly carbohydrates that resist 
digestion in the small intestine. After reaching the large intestine, they are fermented 
by the microflora and support a favourable enteric microbial balance. Roberfroid 
(2007) defined prebiotics as “a selectively fermented ingredient that allows specific 
changes, both in the composition and/or activity of the gastrointestinal microflora that 
confers benefits upon host well-being and health”. It is vital to supply probiotic 
bacteria with fermentable carbohydrates as many of their beneficial effects rely on 
their metabolic activities. This includes the activity of enzymes like glucuronidase, 
glucosidase and nitroreductase as well as end products of fermented fatty acids, 
amino acids, sterols, and mucins. 
Roberfroid claimed three criteria to be fulfilled for classification of prebiotics: 
- resistance to gastric acidity, hydrolysis by mammalian enzymes, and 
gastrointestinal absorption, 
- fermentation by intestinal microflora, and 
- selective stimulation of the growth and/or activity of those intestinal bacteria 
that contribute to health and well-being.  
Furthermore, Roberfroid grouped prebiotics in two main categories: inulin-type 
prebiotics, which include fructooligosaccharides, oligofructose and inulin, and 
galactooligosaccharides (GOS). These complex carbohydrates are neither absorbed 
by the host nor utilised by the majority of gram-negative bacteria (Collins et al., 
1998). Further prebiotic candidates exist, like glucooligosaccharides, isomalto-
oligosaccharides, soybean oligosaccharides, xylo-oligosaccharides, gentio-
oligosaccharides, lactosucrose, polydextrose, but have to be examined in more detail 
to prove their eligibility. 
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Inulin-type prebiotics have been studied extensively. In 2010, Patterson et al. 
conducted a study on inulin supplemented diet on young pigs. Inulin is a general term 
comprising ß-fructans of varying chain lengths. Although it is not hydrolysed by 
mammalian digestive enzymes, it becomes significantly degraded in the ileum - 
mainly fermented by bifidobacteria. Patterson demonstrated in experiments with 
young pigs that upon ingestion of inulin populations of beneficial bifidobacteria and 
lactobacilli were enhanced with reductions in less desirable bacteria as Clostridium 
spp. and that iron status of prebtioic-fed animals improved. They also demonstrated 
downregulation of inflammation-related genes in the colonic mucosa. Others 
demonstrated a beneficial influence of inulin-type prebiotics on mineral absorption in 
human and animal models (Griffin et al., 2003; Ohta et al., 1995). 
GOS are derived from lactose by transgalactosylation, where any sugar molecule 
can be used as a nucleophile accepting the galactosyl. Most bifidobacteria and 
lactobacilli are able to metabolize GOS that serve as nutrients for themselves and 
other probiotic bacteria (Saulnier et al., 2007).  Their numbers increase, while 
pathogenic bacteria, like Bacteroides decrease upon ingestion of these 
oligosaccharides (Ito et al., 1993). L. reuteri has both a α- and ß-galactosidase that is 
able to transfer galactose from lactose to other lactose molecules, building 
galactooligosaccharides. Especially the ß-galactosidase of L. reuteri has been 
subject to intensive research and genetic engineering with the aim to increase 
production of GOS. The oligosaccharides could be used as plain prebiotic products, 
in combination with probiotic products or even genetically altered L. reuteri could be 
administered as a whole to poultry, pig and more. 
GOS increase the production of short chain fatty acids in the colon, hence 
facilitating calcium and magnesium absorption and energy supply to the colonic 
epithelium in humans (Sako et al., 1999). Tzortzis et al. (2005) investigated the 
prebiotic effect of GOS in weaned pigs; they reported reduced pH in the proximal 
colon, increased amounts of short chain fatty acids and reduced attachment of 
enteropathogenic E. coli and Salmonella enterica. The concept is that GOS might 
competitively bind bacteria and prevent attachment to the gut epithelium by acting as 
a functional mimic for bacterial receptors. The tested GOS mixture was also shown to 
selectively raise bifidobacterial populations. 
Prebiotics can be incorporated in several probiotic products, supporting the 
viability of the targeted probiotic strain; such a combination is termed a synbiotic. 
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These compoundings have to be tested and well matched to ensure optimal boost of 
desired probiotic strains. 
The concomitant administration of L. reuteri and its own oligosaccharides was 
shown to enhance specifically growth of the strain itself, but also bifidobacteria 
(Rastall, 2004). A study combining L. reuteri with soybean oligosaccharides resulted 
in higher resistance of L. reuteri to bile salts and increased bioavailabilty of 
isoflavones (De Boever et al., 2001). 
A future aim is to design species-specific prebiotics and therefore to ensure 
growth of targeted microbial populations in the gastrointestinal tract, producing 
tailored synbiotics for specific health attributes. 
Pro- and prebiotics should be administered thoughtfully, as dose-related adverse 
effects like flatus, bloating, abdominal cramps and diarrhoea are possible due to 
excessive fermentation or osmotic potential of certain carbohydrates (Holzapfel and 
Schillinger, 2002). 
1.4. Genetic engineering of lactic acid bacteria 
 
Lactic acid bacteria are used to produce proteins for the food industry, metabolites, 
enzymes and proteins of therapeutic value including antigens, cytokines, and pro- 
and prebiotics. This is mainly achieved by genetic engineering which allows for 
introduction of foreign genes, modulation of gene expression, and efficient secretion 
(De Mey et al., 2010). Genetic engineering is therefore aimed to be improved 
constantly. 
Metabolic processes like production of GOS by L. plantarum and L. reuteri can 
be enhanced by introducing strong constitutive promoters upstream of genes coding 
for the relevant enzymes (De Mey et al., 2010). Production of GOS would therefore 
occur exactly at the site where probiotic bacteria reside. The promoter of lactate 
dehydrogenase is one possible candidate for overexpression purposes. LDH is a 
highly active enzyme needed to relieve the cell constantly of accumulated NADH and 
to regenerate NAD+.  
Up to date several tools for genetic engineering have been successfully tested 
and established. They are crucial for protein production in dairy and food industry. 
Efficient expression vectors have already been developed for Lactococcus (Wells et 
al., 1993) where expression of recombinant proteins is ensured by constitutive 
promoters or inducible systems. The most common controllable expression systems 
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are based on either lactose-inducible transcription of the lac operon or on the food-
grade inducer nisin. Nisin is a bacteriocin which was discovered in Lactococcus 
lactis. It induces transcription of the nisA gene via signal transduction mediated by a 
histidine kinase and a response regulator. (Kuipers et al., 1995) The nisin based 
system is suitable for food-grade and controlled overproduction of desired proteins. 
Strains have to be chosen that are known for their efficient secretion of recombinant 
proteins for industrial protein production. The capacity to secrete heterologous 
proteins varies from species to species. Hols et al. (1997) demonstrated the ability of 
L. plantarum to secrete up to 10 mg/L of a specific antigenic fusion protein.  
It is advisable to use intra-species promoters if the recombinant organism itself 
is administered to avoid adverse effects and to ensure safety of the final customer. 
Furthermore, it is absolutely necessary to work with GRAS bacteria only to avoid 
health risks otherwise imposed on the patient. Further prerequisites are tolerance to 
low pH and bile salts if the gut is the designated destination.  
A crucial advantage of LAB and their applications is that most lactic acid 
bacteria have GRAS status (= generally regarded as safe), which means that they 
have no recorded toxic or pathogenic activity. Nevertheless, occasionally there are 
case reports on systemic infections caused by LAB in immunocompromised hosts. 
For instance, L. rhamnosus was identified as causative agent in endocarditis 
(Mackay et al., 1998; Sipsas et al., 2002). Also enterococcus should be avoided as a 
model for live vectors, as multi-resistant enterococci are able to transfer resistance 
plasmids to S. aureus (Noble et al., 1992). 
Regarding the high standards of security it would be advantageous to succeed 
in genetic engineering and transformation of L. reuteri. Others have expressed the ß-
galactosidase from L. reuteri in E. coli leading the way to industrial production of 
galacto-oligosaccharides (Nguyen et al., 2007).  The ß-galactosidase could also be 
overexpressed in yeast or other food-grade systems yielding GOS for pre- or 
synbiotic products, but administration of live recombinant probiotics needs 
intraspecies genetic engineering, i.e. enhancing the ß-galactosidase gene by 
introducing a promotor of a household gene of L. reuteri into L. reuteri. 
One prospering field – as an example - based on genetic engineering is 
metabolic engineering. The main outcome of fermentation in lactic acid bacteria can 
be shifted to acetic acid, diacetyl, acetaldehyde, and ethanol. These by-products can 
be accumulated by disruption or overexpression of metabolic genes. Disruption of the 
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ldh-gene in L. plantarum and L. lactis inhibited further production of lactic acid and 
resulted in mixed acid fermentation (Platteeuw et al., 1995; Ferain et al., 1998). 
Additionally, cloning of ethanol genes, coding for alcohol dehydrogenase and 
pyruvate decarboxylase, derived from an efficient ethanol-producing bacterium in 
LDH-negative lactobacilli highly improved ethanol yields. L. lactis engineering was 
also used successfully to increase production of the butter aroma compound diacetyl 
and the amino acid alanine (Hugenholtz and Kleerebezem, 1999; Hols et al., 1999), 
while metabolic engineering in Lactobacillus fermentum aimed at producing high 
levels of mannitol, L-lactic acid and pyruvate, needed in large quantities for the 
synthesis of biopolymers and pharmaceuticals (Li et al., 2001). 
 
1.5. Electrotransformation 
 
1.5.1. General aspects of electrotransformation 
 
Electroporation is a method aiming to introduce DNA into foreign cells and therefore 
a crucial tool in genetic engineering. An electric field is applied to a mixture of 
plasmids and electrocompetent cells to stimulate DNA uptake.  Although the method 
is widely used, the molecular process itself remains unknown.  
Xie et al. (1990) worked on E. coli and proposed that DNA is absorbed on the 
cell surface and transfers into the cell after formation of membrane pores by 
induction of an overcritical membrane potential during the electric pulse. Required 
field intensities are either reached by appliance of high voltage or usage of narrow 
electroporation cuvettes. After membrane pores are formed, the negatively charged 
DNA is supposed to move into the cells in an electrophoresis-like manner. 
Xie et al. (1990) hypothesized that the membrane might take an active role in 
plasmid absorption. Extracellular structures, like exopolysaccharides, S-layers and 
pili, are thought to be an obstacle to plasmid interaction and efficient electroporation, 
as well as thick cell-walls that might be more difficult to penetrate.  Parameters, like 
choice of growth medium, growth temperature, treatments affecting cell wall 
organization, and more, have to be optimized, as they differ extremely from species 
to species. 
Electrical parameters, like pulse duration, field strengths, resistance of the 
sample, and many more have a crucial influence on successful penetration. A 
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prerequisite of effective electrotransformation is to apply high field intensities to 
bacterial solutions. This can be achieved either by narrowing the width of 
electroporation cuvettes or increasing the applied voltage. The voltage across the 
electrodes rises to a peak voltage and declines in an exponential waveform. A built-in 
resistor determines the decay time of the field applied on the sample (Eynard and 
Teissié, 2000). The time constant which expresses pulse length is usually set at 5 
ms. Lower constants may indicate a failure in pulse delivery and are therefore 
monitored in every experiment. 
Thorough washing of the sample is important as not to increase the 
conductivity by residual ions, to keep resistance high, and to avoid arcing. 
Gram-negative bacteria are usually the easiest ones to electroporate. In many 
cases, transformants can be obtained by simply removing ions and salts through two 
or three washing steps. Thorough washing is important to avoid arcing; otherwise the 
charge is conducted through the medium causing severe damage to the 
electroporated cells and loss of viability. 
In a last step, cells are usually washed and resuspended in an electroporation 
solution like aqueous glycerine or PEG - lowering the conductivity of the sample - 
before applying a pulse. Electroporation itself is carried out at ice-cold temperatures 
to avoid heat damage to the cells. During the pulse the electric energy is converted 
into heat, increasing the temperature of the sample. 
It is also advisable to incubate cells with plasmids before electroporation to 
increase contact and absorption of plasmids to the cell surface. Pre-incubation at low 
temperatures might additionally inhibit extracellular nucleases and degradation of 
plasmid DNA. 
1.5.2. Electrotransformation of LAB 
 
Electrotransformation of gram positive LAB usually requires additional steps to 
transcend the rigid cell wall. A panoply of cell pre-treatments has already been 
proposed to alter cell wall structure of refractory gram-positive strains.   
Glycine is added to the growth medium to replace D-alanine of peptidoglycan 
precursors and to reduce cross-linking by being a poor substrate for transpeptidation 
(Dunny et al., 1991); threonine inhibits diaminopimelic acid incorporation in 
peptidoglycan (McDonald et al., 1995), while treatment with lysozyme removes 
partially the cell wall (Powell et al., 1988). Haynes and Britz (1989) reported that 
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Tween80, an emulsifier known to prevent clumping of mycobacteria, changes the 
mycolic acid composition of corynebacteria, Palomino et al. (2010) proposed the use 
of NaCl as a cell-weakening agent for Lactobacillus transformation. In 2007, 
Papagianni et al described successful transformation of Lactococcus lactis using 
lithium-acetate and DTT, which are common in yeast transformation. 
The milestones in establishing methods for electroporation of LAB include 
growth in glycine and sucrose (Holo and Nes, 1989), the use of PEG as 
electroporation or storage solution (Aukrust and Blom, 1992), and thorough testing of 
suitable electrical parameters (Axelsson and Ahrne, 1990). 
Nevertheless parameters, like choice of cell-wall weakeners or electrical 
settings, depend on the strain. Even within the same species the susceptibility to 
electrotransformation procedures and physiological needs are significantly diverse. 
Every strain itself has to be examined thoroughly to develop an operative 
electrotransformation protocol. 
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2. Objective 
 
 
One aim of this work was to compare the effectiveness of selected published 
electrotransformation protocols for our industrial LAB strains derived from the genera 
Lactobacillus, Lactococcus and Enterococcus. Electrotransformation is a prerequisite 
for effective genetic engineering in industrial applications.  
 
We paid special attention to the development of an electroporation method for a 
specific industrial L. reuteri strain by examining growth media, washing solutions and 
electrical parameters. 
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3. Materials and Methods 
3.1. Materials 
3.1.1. Microorganisms 
 
Lactobacillaceae    
Lactobacillus plantarum CD032 
Lactobacillus plantarum CD033 
Lactobacillus buchneri CD034 
Lactobacillus buchneri CD035 
Lactobacillus reuteri CD037 
Lactobacillus reuteri DSM 20016 
 
Enterococcaceae 
Enterococcus faecium CD036 
 
Streptococcaceae 
Lactococcus lactis MG1363 
 
Enterobacteriaceae 
Escherichia coli JM109 
 
3.1.2. Equipment 
 
Table1. Equipment 
Supplier Device 
SCIE-PLAS (UK),  
Beckman Coulter (USA) 
agarose gel units (Midi Horizontal Gel Unit, 
Avanti J-20-XP) 
Eppendorf (Germany),         
Jouan (Germany) 
centrifuges (5415 D, C312)                                                                                                                                                             
 
Heraeus (Germany) class II laminar flow (Herasafe) 
Hoefer (USA) gel caster (260 series) 
Bio-Rad (USA) gel documentation system (GelDoc 2000) 
WTB-Binder (Germany),  
Heraeus (Germany) 
incubators (B 115, BK 6160) 
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Supplier Device 
WTW (Germany) pH meter (pH 521) 
Sartorius (Germany), 
Mettler-Toledo (Germany) 
scales (A-120-S, SM-L) 
Implen (Germany) NanoPhotometer 
BTX Harvard apparatus 
(USA) 
electroporator (ECM 630 Precision Pulse) 
UVP (USA) transilluminator  Benchtop 3UV  
peqLAB (Germany) spectrophotometer (NanoDrop1000) 
Greiner Bio-One (Germany) pipette tips, centrifuge tubes 
 
3.1.3. Reagents 
 
Table 2. Reagents 
Supplier Reagents 
Roth (Germany) Tris, DMSO, EDTA, MRS agar and bouillon, 
salts, sugars, peptone, agar agar 
Sigma (Germany) Tween80, ethidiumbromide, ammonium 
citrate, glycine, sodium acetate, HEPES 
Invitrogen (USA) agarose 
Oxoid (UK) M17 broth and agar 
Riedel-de Haen (Germany) MnSO4 
Fluka (Switzerland) meat extract, MgSO4, yeast extract 
 
 
3.1.4. Growth media 
 
Media were prepared with deionized water and sterilized by autoclaving at 120 °C for 
20 minutes. Sensitive reagents like glycine or antibiotics were sterile-filtered. 
Growth media for LAB 
 
MRS Bouillon 
10 g/L peptone 
4 g/L yeast extract 
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8 g/L meat extract 
2 g/L di-potassium hydrogen phosphate anhydrous 
5 g/L sodium acetate 
2 g/L ammonium citrate tribasic anhydrous 
0.4 g/L magnesium sulfate heptahydrate 
0.056 g/L manganese(II) sulfate-1-hydrate 
1 g/L Tween 80 
20 g/L glucose  
 
Maillard reaction during autoclaving resulted in dark-coloured MRS. 
Glucose was autoclaved separately, where light-coloured MRS Bouillon was needed. 
 
MRS agar 
MRS bouillon was supplemented with 10 g/L agar agar before autoclaving. 
 
M17 broth 
5 g/L tryptone 
5 g/L soy peptone 
5 g/L “Lab-Lemco” powder 
2.5 g/L yeast extract 
0.5 g/L ascorbic acid 
0.25 g/L MgSO4 
19.0 g/L di-sodium-glycerophosphate 
Glucose and lactose were added after separate autoclavation. 
 
Growth media for E. coli 
 
LB medium 
peptone 10 g/L 
yeast extract 5 g/L 
sodium chloride 10 g/L 
 
LB agar 
LB medium was supplemented with 15 g/L agar agar before autoclaving. 
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3.1.5. Antibiotics  
 
Ampicillin and Chloramphenicol were purchased from Roth (Germany). Ampicillin 
was used for E. coli in LB medium with a concentration of 100 µg/mL. 
Chloramphenicol was used both for E. coli and LAB in different concentrations.  MRS 
was supplemented with 5 µg/mL chloramphenicol , LB with 25 µg/mL.  
 
Ampicillin 
stock solution: 100 mg/ml (in ddH2O) 
 
Chloramphenicol 
stock solution: 25mg/ml (in EtOH) 
3.1.6. Enzymes 
 
KOD polymerase was purchased from Novagen (USA), HybriPol from Bioline (UK)
  
3.1.7. Primers 
 
Primers for colony PCR 
pUC19_for 
5„-AGTTGCGCAGCCTGAATGG-3„ 
CATseq_back 
5„-GTTATTGGGATAAGTTAGAGC-3„ 
3.1.8. Plasmids 
 
The vectors are based on pUC19 containing a chloramphenicol acetyl transferase 
(CAT) gene from pC194 for selection in LAB. Each one has an additional ori to 
improve replication in LAB.  pCDWV01 is a minimal version of pCDW01 lacking the 
pMB1 ori and the ampicillin resistance gene. (Leenhouts et al., 1991; 
Kiewiet et al., 1993; Sørvig et al., 2005; Gryczan et al., 1982.) 
 
 
 
Table 3. Plasmids used in the study. 
plasmid donor plasmid of ori replication donor organism 
pCDW01 pWV01 rolling circle Lactococcus lactis 
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pCDWV02 pWV02 theta replication Lactococcus lactis 
pCD256 p256 rolling circle L. plantarum 
pCDE194 pE194 rolling circle B. subtilis 
 
 
Figure 1. Map of the pCD vectors carrying an origin of replication from either 
Lactococcus lactis, L. plantarum or B. subtilis (LAB ori) designated for replication in 
lactobacilli, an origin of replication for optimised replication in E. coli (pMB01 ori), a 
multiple cloning site and two antibiotic resistance genes.  
 
 
 
 
Figure 2. Map of pCDWV01, derived from pCDW01, containing a Lactococcus ori, a 
multiple cloning site and a chloramphenicol resistance gene. 
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3.2. Methods 
3.2.1. Growth conditions 
 
Strains were grown – unless otherwise stated – under following conditions.  
 
Table 4. Growth conditions of LAB strains. 
Strain Temperature 
(°C) 
Medium Oxygen 
L. plantarum CD032 30 MRS bouillon no 
L. plantarum CD033 30 MRS bouillon no 
L. buchneri CD034 37 light MRS bouillon yes 
L. buchneri CD035 37 MRS bouillon yes 
E. faecium CD036 37 MRS bouillon yes 
L. reuteri CD037 37 light MRS bouillon no 
L. lactis MG1363 30 M17 no 
E. coli JM109 37 LB yes 
 
3.2.2. Preparation of electrocompetent cells and electroporation 
 
Initial protocol combined with glycine  
(Axelsson and Ahrne, 1990)    
L. plantarum CD032 and CD033  
 
L. plantarum CD032 and CD033 were incubated at 30°C without aeration. The 
cultures were diluted to an OD600 of 0.2 in MRS supplemented with 1% glycine.  The 
cells were harvested at an optical density of approximately OD600 0.6. Centrifugation 
was performed at 10, 000 rcf for 10 minutes to pellet the cells. They were washed 
three times with dH2O, once with 30 % PEG1500 and suspended in fresh 30 % 
PEG1500 (4 mL). Centrifugation were increased in speed and time when necessary. 
40 µL aliquots of resuspended cells were either frozen in liquid nitrogen and stored at 
– 80 °C or used immediately. OD600 of the aliquoted cells was between 11 and 19. 
 
Thawed or freshly prepared aliquots were held 10 min on ice after mixing 1 µg of 
plasmid with each aliquot. The cell solution was transferred into precooled 
electroporation cuvettes; during pipetting trapping of air bubbles was avoided. A 
21 
 
pulse of 2000 V/200 Ω/25 µF was applied to both L. plantarum strains before 
incubation in 360 µL MRS at 30°C for 2 hours. Undiluted and serial dilutions of 
recovered cell suspensions were spread and  incubated on either MRS 
chloramphenicol agar or plain MRS agar. For evaluation of cell survival and 
transformations efficiency it is further necessary to spread cell suspensions before 
the appliance of an electric pulse. Transformant colonies are visible after two days in 
general. 
 
L. buchneri CD034 
 
An overnight culture of L. buchneri CD034 in MRS was diluted to an OD600 = 0.2 and 
supplemented with 1% or 2% glycine. Cells were incubated at 37 °C aerobically and 
harvested at 0.4 OD600. Washing and pre-pulse treatment were carried out as above. 
The electrical parameters were set at 2,500 V and 200 Ω (25 µF). L buchneri CD034 
was incubated post-pulse 2 hours in MRS containing 0.5 M sucrose at 37 °C with 
agitation and plated on MRS agar with chloramphenicol. 
 
L. buchneri CD035 
 
L. buchneri CD035 was incubated at 37 °C overnight in MRS under oxidative 
conditions. The cells were diluted to OD600 = 0.2 in MRS 1% glycine and harvested at 
0.4 to 0.5 OD600. Washing and aliquotation were performed as described above. 
Electrical parameters of 2,500 V/200 Ω (25 µF) were applied to L. buchneri CD035 
and cells were incubated in MRS 0.5 M sucrose at 400 rpm at 37 °C for 2 hours 
before plating on MRS chloramphenicol plates. 
 
Lithium-acetate method  
 
Overnight cultures were grown under strain-specific conditions (see 3.2.1) and 
diluted to an OD600 of 0.2. Cells were harvested after reaching an OD600 of 0.4 – 0.6. 
Cells were centrifuged for 15 min and resuspended in 30 mL lithium acetate solution 
(0.6 M sucrose, 100 mM lithium-acetate, 10 mM Tris-HCl, pH 7.5). 120 mL of lithium 
acetate-DTT (0.6 M sucrose, 100 mM lithium-acetate, 10 mM Tris-HCl, pH 7.5, 10 
mM DTT) solution were added and the cell solution was incubated for 30 min at room 
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temperature and 50 rpm. The suspension was washed twice with ice-cold 0.3 M 
sucrose, once with 25 mL 50 mM EDTA and again twice with 0.3 M sucrose. The 
cells were resuspended in 0.3 M sucrose. Electrical parameters were set as 
described for the initial protocol. 
 
High efficiency protocol for Lactococcos lactis (Papagianni M. et al, 2007) 
 
Overnight cultures of L. lactis were grown in M17 supplemented with 0.5 % glucose 
and 40 mM threonine and diluted 1:12.5 in 25 mL of M17 with glucose. Cells were 
harvested at OD600 ~ 0.3 and suspended at room temperature for 30 minutes in 8 mL 
of 100 mM LiAc, 10 mM DTT, 0.6 M sucrose, and 10 mM Tris-HCl, pH 7.5. Following 
pretreatment, cells were washed twice with ice-cold ddH2O, once with 50 mM EDTA, 
ddH2O and twice with 0.3 M sucrose. Cells were immediately electroporated by a 
single pulse at 2.5 kV, 200 Ω and 25 µF using 1 µg of DNA. The cell suspension was 
diluted in 5 mL M17 containing glucose and 1% sucrose and incubated for 2 hours at 
30 °C. 
 
High salt protocol  
(Palomino et al., 2010) 
 
Cells were cultured for 21 hours at 37 °C without aeration. 1 mL of preculture was 
diluted in 49 mL MRS supplemented with 0.4 M – 0.7 M NaCl and incubated for 22 
hours. Cells were washed three times with ice-cold ddH2O and resuspended in 900 
µL ddH2O. 50 µL aliquots were electroporated with 2.5 kV and 200 Ω (25 µF). 
 
3.2.3. L. reuteri CD037 
Cultivation experiments 
 
L. reuteri CD037 was incubated overnight in light MRS, dark MRS and M17 broth.  
Growth and cell aggregation in light MRS were protocolled after adding D-glucose, D-
sucrose, D-maltose, D-xylose, D-galactose, D-fructose and Ca-L-lactate (10 g/L). 
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Agglutination was also compared in light MRS supplemented with different Mg2+ (0, 
0.001, 0.02, 0.05 M) or Ca2+ (0, 0.001, 0.02, 0.05 M) concentrations using MgSO4 
and CaCl2.  
Optimization of electrical parameters and initial protocol for electroporation  
 
Based on Axelsson and Ahrne (1990), an overnight culture of L. reuteri CD037 was 
grown in MRS at 37 °C and diluted in 40 mL fresh MRS to an OD600 of 0.2. After 
growth at 37 °C  to an OD600 of 0.5 – 0.7, cells were harvested by centrifugation at 4 
°C, washed three times in ice-cold ddH2O and once in 30 % PEG1500. The cells were 
suspended in 30 % PEG1500 leading to an OD600 of 10 to 20 and aliquoted into 40 μL 
portions. The suspensions were electroporated without addition of plasmids to 
determine survival rates. Different combinations of voltage and resistance were 
applied; capacity was set at 25 µF. 
 
Table 5. Different combinations of voltage and resistance at 25 µF. 
V 1,000 1,000 1,500 1,500 2,000 2,000 2,500 2,500 
Ω 800 400 800 400 400 200 400 200 
 
The electrotransformation protocol was repeated, adding 1 µg of pCD plasmids, 
respectively, to the aliquoted cells.  DNA and cells were mixed and held 10 min on 
ice prior to electroporation. After application of  the electric pulse, cells were diluted in 
360 µL MRS and incubated for 2 hours at 37 °C, before plating them on MRS agar 
containing 5 µg/mL chloramphenicol. 
 
Protocol modifications 
 
The initial protocol was conducted with minor changes. Glycine was added to the 
growth medium as a cell weakening agent. An overnight culture was diluted in MRS 
containing 2 % glycine. Washing and electroporation were performed a described 
above. After application of the pulse, cells were incubated for 4 hours at 37 °C in 
MRS supplemented with 0.5 M sucrose as an osmotic stabilizer. 
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Washing solutions 
 
Further actions were taken concerning the composition of the washing solution.  
L. reuteri CD037 was grown in MRS overnight, incubated in MRS + 2% glycine and 
harvested. Following centrifugation, cells were resuspended in either 3 mL high salt 
buffer (0.75 M NaCl, 0.05 M Tris, 0.025 M EDTA), 0.5 M NaCl, 0.05 M NaOH or 
0.025 M NaOH. Cells were incubated for 15 to 20 min on ice and then washed three 
times with ddH2O and once with PEG1500 30 %. The aliquots were incubated with 
pCDWV015 10 min on ice before applying a single pulse of 2000 V/200 Ω (25 µF). 
Post-pulse the cells were diluted in MRS 0.5 M sucrose and incubated 4 hours at 
37°C. Plating on MRS agar was performed to confirm cell survival. 
A succeeding experiment was conducted by growing L. reuteri CD037 in MRS 
to an OD600 of ~ 0.6. The culture was harvested by centrifugation and incubated for 
either 15 minutes in 50 mM EDTA on ice, or for 20 minutes in lysozyme (25 mg/mL) 
at 37 °C.  The cell pellet was washed three times in ddH2O.  The resulting cell 
solutions were examined under the microscope. 
 
Glycine concentrations 
 
An overnight culture was diluted in MRS containing different concentrations of glycine 
(0, 1, 2 or 3 %).  After reaching a sufficient density (OD600 ~ 0.6), each culture was 
split in 4 fractions and incubated 15 min on ice with 0, 1, 10 or 50 mM MgCl2, 
respectively.  MgCl2 was further used as washing solution, following one washing 
step with 30 % PEG1500. Due to the increased ionic content of the cell suspension, 
2000 V/400 Ω/25 µF were applied to the aliquots incubated with 1 µg of pCDWV01. 
Lithium-acetate method  
 
The method was applied as described in 3.2.2. after supplementing light MRS either 
with xylose, glucose or galactose. 
 
Protocol for Lactococcus lactis  
(Holo and Nes, 1989) 
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The original protocol is based on Lactococcus lactis. Growth conditions were adapted 
from 30 °C in M17 medium with 0.5 % glucose to 37 °C in MRS with 0.5 % glycine. L. 
reuteri CD037 was grown until OD600 = 0.5 – 0.8 was reached, diluted 1:100 in MRS 
containing 0.5 % glucose, 0.5 M sucrose and glycine (0, 2, 3, 4, 6 or 8%) and further 
incubated to OD600 = 0.2 – 0.7.  The culture was washed twice in ice-cold 0.5 M 
sucrose, once in 10 % glycerol and resuspended in 0.5 mL glycerol. Aliquots of 40 µL 
were electroporated at 2 kV and 200 Ω (25 µF) and suspended in 960 µL ice-cold 
MRS supplemented with 0.5 % glucose, 0.5 M sucrose, 20 mM MgCl2 and 2mM 
CaCl2. Electroporated cells were held on ice for 5 minutes and then incubated for 2 
hours at 30 °C prior to plating on MRS chloramphenicol. 
 
Improved protocol 
(Thompson and Collins, 1996) 
 
The protocol was initally used for L. plantarum, hence we adapted it for L. reuteri 
CD037. Cells were grown over night at 37 °C in light MRS containing 1% glucose. 
The cell culture was diluted to an OD600 of 0.2 in 50 mL MRS with 0.5 % glucose, 0.3 
M sucrose and 8 % glycine. After 4.5 hours of incubation at 37 °C, cells were 
harvested, washed twice in ddH2O, held 5 minutes on ice in 50 mM EDTA, washed 
twice with ddH2O again, once with 0.3 M sucrose and then resuspended in 0.5 mL 
0.3 M sucrose. Cells were diluted after electroporation (2.5 kV, 200 Ω, 25 µF) in 360 
µL pre-warmed MRS supplemented with 0.5 M sucrose and incubated for 2 hours at 
37 °C.  The suspension was plated on MRS agar containing chloramphenicol.  
 
3.2.4. Biomolecular methods 
Preparation of plasmid DNA 
 
Plasmids (pCD) were prepared from E. coli JM109 using either the midi-prep kit 
(Promega, Germany) or the mini-prep Nucleospin plasmid kit (Macherey-Nagel, 
Germany).  E. coli JM109 containing pCDWV01 was grown in LB supplemented with 
chloramphenicol, while ampicillin was used for selection of E. coli JM109 carrying the 
other pCD plasmids.  
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Polymerase Chain Reaction 
 
PCRs were performed to confirm transformation of lactobacilli with pCD plasmids. 
KOD 
 
The KOD polymerase has a 3` 5´ exonuclease-dependant proofreading function 
and was purchased from Merck (Germany). 
 
KOD protocol 
The master mix was usually split to 50 µL aliquots. 
 
Table 6. Composition of KOD mastermix. 
KOD buffer 10x 5.0 µL 
dNTPs (2 mM each) 5.0 µL 
MgCl2 (25 mM) 3.0 µL 
KOD DNA polymerase (2.5 U/µL) 0.4 µL 
sense primer (10 pmol/ µL) 2.0 µL 
anti-sense primer (10 pmol/ µL) 2.0 µL 
template DNA (0.006 – 6 ng) 1.0 µL 
ddH2O added to 50 µL 
 
Table 7. Thermocycler program for KOD polymerase. 
Step 1 98 °C  35 sec  
Step 2 Tm – 5 °C 15 sec 
Step 3 72 °C 25 sec/2 kbp 
Step 4 72 °C 5 min 
 
Steps 1 to 3 were repeated 30 times.  
 
Hybrid Pol 
 
(Novagen, USA) 
Table 8. Composition of HybridPol mastermix. 
Hybrid Pol buffer 10x 5 µL 
dNTPs (10 mM) 0.5 µL 
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sense primer (10 pmol/ µL) 0.75 µL 
 
 
anti-sense primer (10 pmol/ µL) 0.75 µL 
RNase A 0.1 µL 
DMSO 0.5 µL 
MgCl2 (50 mM) 2 µL 
Hybrid polymerase 0.5 µL 
ddH2O add to 50 µL 
 
 
Table 9. Thermocycler program for Hybrid polymerase. 
Step 1 94 °C 3 min 
Step 2 94 °C 15 sec 
Step 3 Tm -5 °C 30 sec 
Step 4 72 °C 1 min 
Step 5 72 °C 10 min 
 
Steps 2 to 4 were repeated 35 times. 
 
Gel electrophoresis 
 
Agarose gel electrophoresis was performed at 130 V for analytical gels (15 – 20 
minutes) and with 110 V for preparative gels (30 – 40 minutes). Samples were mixed 
with 6x BX buffer (0.25 % bromphenol blue, 0.25 % xylen cyanol, 30 % glycerol). 6 
µL of 2-log DNA ladder (0.1 – 10 kb; New England Biolabs, UK) were applied to a 1 
% agarose gel (1% agarose in 1xTAE buffer) to determine DNA length of fragments.  
Gels were supplemented with ethidiumbromide (9*107 M) and run in TAE buffer (40 
mM Tris-acetate, 100 mM EDTA). 
 
DNA extraction from gels and purification 
 
We used two distinct kits for extraction and purification of PCR products, either the 
QIAEX II Gel Extraction Kit (QIAGEN, USA) or the PCR clean up kit (Macherey-
Nagel, Germany).  
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4. Results and Discussion 
4.1. Transformation of L. reuteri CD037 
 
4.1.1. Growth media 
Selection 
 
Our first aim was to identify an optimal growth medium for L. reuteri CD037 and then 
to alter it in favour of cell wall weakening processes. Several media have already 
been used in successful electroporation protocols dealing with the type strain L. 
reuteri DSM 20016, like MRS bouillon (Lizier et al., 2010) and LCM medium 
(Axelsson and Ahrne, 1990). It is advantageous to use highly cell growth-promoting 
media, as effector agents like glycine, sucrose and salts are known to decelerate 
growth (Holo and Nes, 1989; Palomino et al., 2010). 
Although we had guidelines and electroporation models from articles on the 
other L. reuteri strains, L. reuteri CD037 turned out to be the most challenging strain 
of all lactic acid bacteria we were examining. The most obvious feature was its 
clumping in liquid MRS bouillon, which was not observed in the type strain. This 
property aggravated accurate OD600 measurements. Furthermore we thought that 
exopolysaccharides responsible for clumping might obstruct absorption of plasmids 
to competent cells and consequently inhibit transformation.  
Therefore we compared three different frequently used LAB media not only for 
their ability to propagate L. reuteri CD037 but also to enhance cell dispersion. 
Our strain showed very scarce growth in commercial MRS Bouillon and GM17 
while clumping was still obvious. Only light MRS seemed to match the nutritional 
needs of L. reuteri CD037, although unable to inhibit cell aggregation. We decided to 
use variations of light MRS for our further examinations. 
 
Carbon source 
 
Microorganisms are usually able to catabolize a wide variety of carbons and to even 
prosper in poor conditions depending on the metabolic pathways they possess. In 
contrast, most LAB show a limited ability to synthesize essential metabolites like 
amino acids and nucleic acids probably due to their specialization on nutrient rich 
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habitats. However, as they are surrounded by an excess of different sugars, they 
might be able to catabolize those sugars in different metabolic pathways.  
Lactococcus lactis was shown to produce less exopolysaccharides (EPS) 
when grown on fructose rather than on glucose (Petronella et al., 1999). This was a 
result of the low activity of fructosebisphosphatase that is involved in production of 
sugar precursors when cells are grown on fructose and of the fact that the EPS 
precursors are used both in EPS biosynthesis and in cell wall formation.  
Experiments indicate that precursors, when scarce, are preferentially used for 
the formation of cell wall sugars. A lack in precursors will therefore result in less EPS 
production.  This phenomenon is common to many lactobacilli, as shown in L. casei, 
L. rhamnosus, and L. delbrueckii (Cerning et al., 1994; Gamar et al., 1997; Grobben 
et al., 1997) cultivated in fructose. Hence, we tested a putative impact of different 
carbon sources on agglutinative growth of L. reuteri CD037. 
The choice of carbon source did influence the shape of growth curves (Fig.3), 
indicating that different metabolic pathways were active and in some cases had to be 
induced. Nevertheless, there was no effect on cell clumping.  Agglutination occurred 
with glucose, saccharose and maltose equally. A following experiment using 
galactose, lactate, fructose and xylose led to the same results. We also tested 
reduced concentrations of glucose to directly limit production of EPS precursors 
which resulted in lower growth but unchanged agglutination.  
As glucose is typically used as a carbon source in microbiology and did not 
display any disadvantages compared to the other tested carbon sources, we decided 
to use it further on in MRS bouillon according to the manufacturers recommended 
concentration. 
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Figure 3. Growth curves of Lactobacillus reuteri CD037. Cells were grown at 30 °C in 
MRS Bouillon containing different carbon sources. 
 
Divalent cations 
 
Agglutination might also be a stress response, due to a lack of specific nutrients like 
vitamins or trace elements. In fact, certain micronutrients like ions might have an 
effect in either a metabolic or physicochemical way. Minerals like magnesium, 
calcium and iron are essential in metabolism and might therefore have a critical 
impact on growth performance of microorganisms.   
Considerable studies state that divalent cations like magnesium and calcium 
are able to induce morphological changes in microorganisms.  Many sites on gram-
positive walls harbouring carboxyl, phosphoryl or secondary polymers have the 
potential to bind divalent cations (Beveridge, 1989). Yousef and Espinosa-Urgel 
(2007) characterized proteins involved in cell-cell-adhesion and cell surface 
interactions and found that many of these proteins contained Ca2+-binding domains, 
a further mechanistic explanation for a putative effect of Ca2+ ions.  
To this end, we decided to test different magnesium and calcium 
concentrations in the growth medium. The addition or reduction of those cations 
resulted in no obvious effect on L. reuteri CD037. All samples agglutinated heavily 
with long filament chains being visible under the microscope. Freely dispersed 
filaments were scarce. 
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Up to date findings on the effect of divalent cations in the growth medium do not 
seem to be coherent. Cell aggregation was shown to be enhanced by calcium ions 
for example in E. coli (Onoda et al., 2000), C. trachomatis (Majeed et al., 1993) and 
S. hygroscopicus (Dobson L. F. and O‟Shea D., 2008). In contrast, magnesium 
increased surface hydrophobicity of E. coli (Latrache et al., 2000), while Dobson et 
al. (2008) found S. hygroscopicus to be hydrophilic and freely dispersed when grown 
in magnesium-rich medium. Cell surface hydrophobicity was usually determined by 
measuring the contact angle between a bacterial cell layer and a deposited drop of 
distilled water (Thaveesri et al., 1995). 
However, we did not observe any effect of magnesium or calcium 
concentrations on agglutination of L. reuteri CD037. 
 
4.1.2. Washing solutions 
 
Preparation of electrocompetent cells always includes washing steps to remove salts 
from the cell solutions and hence increase the resistance of the sample. High 
resistance may also be sustained by the addition of glycerol or sucrose (Eynard and 
Teissié, 2000). Additionally washing solutions can have a beneficial effect on cell 
dispersion.  Indeed, ions and chelators are frequently used as additives in initial 
washing steps to interfere physicochemically with extracellular polysaccharides or 
cell membranes. Once again there is no golden rule how and which agents to apply. 
For example, Berthier et al. (1996) reported a decrease in transformation efficiency of 
L. sake when MgCl2 was added to the electroporation buffer, while in contrast 
washing the same strain in MgCl2 increased the efficiency. The effect of washing can 
also be as simple as to remove aggregation-promoting factors from the supernatant, 
as has been described by Jankovic et al. (2003) for aggregative Lactobacillus 
gasseri. 
Consequently, we tested different washing solutions for their ability to possibly 
counteract agglutination of L. reuteri CD037. Washing steps with 0.5 M NaCl, 0.05 M 
NaOH or 0.025 M NaOH remained ineffective in comparison to distilled water usage.  
Also incubation with high salt buffer (0.75 M NaCl, 0.05 M Tris, 0.025 M EDTA), 
EDTA (50 mM) or even mild lysozyme treatment (25 mg/mL) was not able to induce 
cell separation. 
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The finding that neither carbon source and cations in the growth medium nor 
the variation of washing solutions promoted cell dispersion made us doubt that an 
extracellular matrix has to be blamed for the aggregative growth of L. reuteri CD037. 
The filaments might also be formed by a defect in autolytic enzymes needed for 
complete cell division, in which case little can be done to increase cell dispersion 
while keeping cells viable. In fact, Williamson and Ward published in 1981 an article 
on autolysin deficiency in B. subtilis and S. pneumonia. They described the 
morphology of mutants as chains of non-separated bacilli which applies perfectly to 
L. reuteri CD037. Additionally they observed a decreased porosity of the cell wall as 
a direct result of autolysin deficiency. A change in cell wall permeability would have 
serious impacts on transformability of strains and explain the difficulties faced with L. 
reuteri CD037. 
 
4.1.3. Alterations of the cell wall 
Glycine 
 
As described before numerous substances like lysozyme, penicillin, and threonine 
are used regularly in electroporation studies to induce changes in the cell walls of 
reluctant gram-positive bacteria. A regularly recurring cell wall weakening compound 
in Lactobacillus transformation is glycine (Thompson and Collins, 1996; Berthier et 
al., 1996; Holo and Nes, 1989).  
We journalized growth of L. reuteri CD037 at different temperatures and 
glycine concentrations (Fig. 4 and 5) to evaluate suitability of glycine for our 
purposes. The concentrations of both 1% and 2% glycine led to a growth reduction of 
more than 50% compared to glycine-free medium. The growth inhibition at 4% 
glycine was already too unfavourable for a fast and easy-to-apply approach. 
It was also obvious that incubation at 37 °C supported faster growth by means 
of needing less time to reach the log-phase. As a result we decided to incubate L. 
reuteri CD037 at 37 °C in all succeeding experiments. 
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Figure 4. Growth curve of L. reuteri CD037 at different glycine concentrations ([%]). 
Bacteria were grown in MRS Bouillon with 1% glucose at 30 °C. 
 
 
 
Figure 5. Growth curve of L. reuteri CD037 at different glycine concentrations [%]. 
Cells were grown in MRS Bouillon with 1% glucose at 37 °C and different glycine 
concentrations. 
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increase in transformability when sucrose was added. The osmotically stabilizing 
agent led to growth retardation when it came to speed and at the same time allowed 
for growth in higher glycine concentrations. Other stabilizers, like rhamnose, 
mannitol, sorbitol or maltose, are known but not as extensively tested in 
electroporation as sucrose. We therefore decided to assess the impact of 0.3 M 
sucrose in MRS medium on growth of L. reuteri CD037. 
The application of the protocol led to similar results as predicted by the 
authors. Pronounced growth was still visible at 4% glycine in contrast to unstabilized 
medium bearing the same glycine concentration (Fig.6). In contrast to the original 
article, we did not observe a delay in log-phase occurrence and we were also not 
able to sustain growth in 6% glycine or higher. 
 
 
Figure 6. L. reuteri CD037 grown at different glycine concentarions [%] supplemented 
with sucrose. Cells were grown at 37 °C in plain MRS bouillon containing 1% glucose 
and MRS with 1% glucose plus 0.3 M sucrose (SMRS) at different glycine 
concentrations (%). 
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4.1.4. Optimization of electrical parameters 
 
Adjusting the voltage and the electropulsators resistance has critical impacts on 
transformation efficiency. 
To determine which electrical settings are suitable for L. reuteri CD037, we 
applied Axelsson and Ahrnes (1990) protocol with minor modifications (3.2.3.). 
Aliquots were diluted to an OD600 = 11-19, resulting in a total count of about 10
8 
CFU/40 µL aliquot. We determined survival rates after 4 washes and electroporation 
under various voltage and resistance combinations (Tab. 10). The resulting disparity 
in survival depending on the different settings was only moderate. Thus we agreed to 
use 2000 V/400 Ω/25 µF and 2500 V/400 Ω/25 µF for further experiments as they 
displayed the lowest survival rates and should therefore have the highest impact on 
cell structure. 
 
Table 10. Cell survival at different voltage and resistance combinations. Washed L. 
reuteri CD037 were treated with different combinations of voltages and resistances 
with a capacity of 25 µF and plated on MRS agar (surviving cells/aliquot contaning 
~108 CFU). 
V Ω surviving cells 
1000 800 4*106 
1000 400 5*106 
1500 800 4*106 
1500 400 8*106 
2000 400 1*106 
2000 200 2*106 
2500 400 7*105 
2500 200 3*106 
 
4.1.5. Electroporation protocols 
 
Initial protocol 
 
Electrotransformation of gram-positive bacteria usually requires at least one step 
where the cell wall is weakened. Axelsson and Ahrne published in 1990 a simple but 
nevertheless effective method to electroporate the L. reuteri type strain DSM 20016. 
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The protocol included growth in Lactobacillus Carrying Medium supplemented with 
glucose until mid-log phase was reached (OD600 = 0.5 – 1), followed by three washes 
in distilled water. Cells were electroporated in 30% PEG1500 and incubated post-pulse 
1.5 hours in growth medium. Axelsson and Ahrne reported transformation efficiencies 
ranging from 107 to 108 transformants/µg DNA. 
We repeated a slightly altered electrotransformation protocol as described 
previously (3.2.3.) for determination of electrical parameters and added 1 µg of pCD 
plasmids, respectively, to the aliquoted cells. Post-pulse incubation time was set at 2 
hours, which is assessed to give cells enough time to recover and resume bacterial 
protein synthesis as the CAT gene itself is known to be rapidly expressed. 
Neither the exposition to 2000 V/400 Ω/25 µF nor to 2500 V/400 Ω/25 µF 
resulted in transformants. 
As a consequence, we modified the initial protocol by diluting the overnight 
culture in MRS containing 2 % glycine. After we applied the pulse, we incubated cells 
4 hours at 37 °C in MRS supplemented with 0.5 M sucrose as an osmotic stabilizer. 
We obtained no transformed cells.  
As we suspected the exopolysaccharides to possibly hinder successful 
transformation, we further adjusted the protocol. We grew cells in MRS overnight, 
incubated them in MRS supplemented with 2% glycine and harvested cells as usual. 
Following centrifugation we resuspended cells in either NaCl (0.5 M) or NaOH (0.05 
M). Plating on MRS agar confirmed sufficient survival of cells; still we obtained no 
transformants on chloramphenicol supplemented agar. 
Our next step included alterations of the washing solution. We decided to use 
MgCl2 instead of pure dH2O. L. reuteri CD037 was repeatedly reluctant to this 
treatment as seen with NaCl and NaOH before. 
Lithium-acetate protocol 
 
Lithium acetate is an agent widely used in yeast electroporation yielding high 
numbers of transformants (Wu and Letchworth, 2004; Cregg and Russell, 1998; 
Thomson et al., 1998). It is used for several transformation methods of intact yeast 
cells followed by a heat shock (Ito et al., 1983) or in combination with dithiothreitol for 
electroporation (Thompson et al., 1998). 
In 2007, Papagianni et al. applied a pre-treatment to L. lactis strains using 
lithium acetate and DTT before conduction of electroporation. According to the 
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authors the combination of lithium acetate with a reducing agent is able to modify 
porosity of treated cell walls and hence increase their permeability. 
We incubated harvested L. reuteri CD037 in lithium acetate supplemented with 
DTT and washed thoroughly with EDTA and sucrose. The treatment did not result in 
transformants. We supplemented the growth medium either with xylose, glucose or 
galactose prior to lithium acetate pre-treatment, but did not detect any differences in 
growth, clumping or transformation efficiency. 
High salt protocol 
 
In 2010, Palomino et al. introduced a cost-efficient method to electrotransform 
lactobacilli. They grew pre-cultures in 0.9 M NaCl and conducted washing of cells 
with ultra-pure water before electroporation. This simple procedure was able to 
transform certain strains of L. casei, L. delbrueckii, L. paracasei, L. plantarum and L. 
acidophilus. 
The effect was speculated to be due to reduced peptidoglycan crosslinking 
which is an advantageous prerequisite for electroporation (Palomino et al., 2010). 
Salts are known to act chaotropic, disrupting hydrogen bonds and van der Waals 
bonds, which may result in sufficient cell wall weakening in certain strains. Osmotic 
stress induced by growth in high salt concentrations has also been reported to 
increase intrinsic autolytic activity and sensitivity to lysis in L. delbrueckii and L. casei 
(Koch et al., 2007; Piuri et al., 2005). 
A work on Bacillus subtilis (Thwaites et al., 1990) confirmed the effect of high 
salt concentrations in rendering cell walls more ductile, while changes in pH and 
even lysozyme treatment had little influence on mechanical properties. Ions are 
presumably able to change the polymer conformation of peptidoglycan and to 
diminish the electrostatic forces between charged groups in the cell wall. 
L. reuteri CD037 was too osmosensitive to grow in 0.9 M NaCl, hence we 
adjusted the salt concentrations to 0.4, 0.6 and 0.7 M and proceeded with the 
protocol as recommended (3.2.2.). We were not able to produce transformants with 
the conditions proposed by Palomino.  
Improved protocol 
 (Thompson and Collins, 1996) 
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In 2010, Lizier et al. transformed L. reuteri DSM 20016 and L. reuteri strains isolated 
from chicken crops to compare the effectiveness and activity of different expression 
vectors. The protocol for their experimental setup was derived from Thompson and 
Collins (1996) who further improved the effect of glycine by adding sucrose. Although 
sucrose itself is inhibitory towards growth it increases transformation efficiencies 
when combined with glycine. Sucrose allowed for high glycine concentrations as up 
to 8 %, probably by acting as an osmotic stabilizer and preventing lysis of weakened 
cells. 
We followed the described protocol using sucrose and 6% glycine. Survival 
rate after electroporation was 2*105 cfu/40 µL (~ 0.2 % survival), but we did not 
obtain transformants.  
 
4.2. Comparison of different electroporation protocols 
4.2.1. Initial protocol 
 
The initial protocol was applied as described before including growth in MRS 
supplemented with the cell wall weakening compound glycine. The treatment 
revealed no effect on L. buchneri CD034, and L. buchneri CD035 while L. plantarum 
CD032 and L. plantarum CD033 were both successfully transformed (Tab.11). 
Lowering the field strength of 2.5 kV to 2 kV in electroporation of L. plantarum CD032 
increased the number of transformants. This could be partly due to higher cell 
survival, but is not a sufficient explanation as electroporation efficiency differences for 
pCDE194 were minimal while efficiency for pCD256 rose 1000-fold compared to 2.5 
kV.  
Transformation efficiencies are also highly dependent on the plasmids used. 
For instance, pCDWV02 was not able to establish in the L. plantarum strains CD032 
and CD033.  
 
Table 11. Transformation efficiencies of L. plantarum (CD032 and CD033), L. 
buchneri (CD034 and CD035), and L. reuteri (CD037) strains grown in 1 % glycine. 
n.t. not tested; cells were aliquoted to an OD600 of 11-19. survival = CFU/aliquot after 
electroporation, plated on MRS agar. 
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Strain 
 
Survival 
Transformants/µg DNA 
pCDWV02 pCD256 pCDE194 pCDWV01 
CD032 (2 kV) n.t. - 6 * 10
3 
1 * 10
2 
3 * 10
3 
CD032 (2.5 kV) n.t. - - 7 * 10
2 
6 * 10
1 
CD033 n.t. - 2 * 10
3
 4 * 10
2 
1 *10
4 
CD034 n.t. - - - - 
CD035 n.t. - - - - 
CD037 7 * 10
5 
- - - - 
 
4.2.2. Lactococcus high efficiency protocol 
 
The protocol described by Holo and Nes (1989) is highly similar to the initial protocol. 
It is distinguished by  
 
- addition of sucrose to the growth medium which improves cell stability and 
allows for higher glycine concentrations 
- glycerol containing washing solutions to avoid arcing of the sample, and  
- divalent cations in the recovery medium to additionally stabilize cell 
membranes (Munreet et al., 2007). 
 
Holo and Nes achieved efficiencies of 103 up to 107 transformants per µg DNA 
depending on the L. lactis strain used.  
The protocol proved successful for electrotransformation of L. lactis MG1363, 
even though with moderate efficiencies (Tab. 12). It was remarkable that colonies of 
two distinct sizes were obtained. Both types were able to proliferate in liquid medium 
containing chloramphenicol which indicates that plasmid was uptaken by both colony 
types and disprove a false positive result. 
 
Table 12. Transformation efficiency of L. lactis MG1363 following the lactococcus 
high efficiency protocol. Colonies differed in size and were counted seperately (small 
colonies + large colonies). survival = CFU/aliquot after electroporation plated on MRS 
agar. 
 
Strain 
 
Survival 
Transformants/µg DNA 
pCDWV02 pCD256 pCDE194 pCDWV01 
MG1363 2 * 10
8
 7 * 10
0 
+ 3 * 10
1
 - + 5 * 10
2
 - 2 * 10
2
 + 4 * 10
4
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4.2.3. Lithium acetate method 
 
We prepared our working strains according to the lithium acetate method prior to 
electroporation. L. plantarum CD032 was impaired strongly in survival and as a 
consequence did not result in transformants, while L. plantarum CD033 and E. 
faecium CD036 were more robust – nevertheless yielding low transformation 
efficiencies (Tab.13). Moderate efficiencies were obtained with L. buchneri CD034 
and partly with L. lactis MG1363. 
Both, E. faecium CD036 and L. lactis MG1363 were equally transformable 
after storage at -80 °C with no reported losses of viability. 
 
Table 13. Transformation efficiencies of L. plantarum CD032 and CD033, L. buchneri 
CD034, E. Faecium CD036, L. reuteri CD037, and L. lactis MG1363 strains 
subjected to lithium acetate and DTT prior to electroporation. Small and large 
colonies were observed in some cases (small colonies + large colonies). survival = 
CFU/aliquot after electroporation plated on MRS agar. 
 
Strain 
 
Survival 
Transformants/µg DNA 
pCDWV02 pCD256 pCDE194 pCDWV015 
CD032 5 * 10
2 
- - - - 
CD033 2 * 10
8 
- 3 *10
1 
4 * 10
0 
7 * 10
1 
CD034 2 *10
8 
1 *10
2 
2 *10
3 
2 * 10
3 
2 * 10
3 
CD036 4 * 10
8 
3 *10
1
 + 2 *10
1 
- - 6 *10
1 
CD037 2 * 10
5 
- - - -
 
MG1363 8 *10
7 
- - - 2 *10
1
 + 3 *10
3 
 
 
4.2.4. High salt protocol 
 
The promising high salt protocol failed to transform most of our strains, although 
proved to be very efficient in several lactobacillal species (Palomino et al., 2010). 
In addition to testing the protocol, we also determined the effect of two varying 
electrical settings for L. plantarum CD032. Lower applied voltage resulted in higher 
survival rates, but no transformants, while increased voltage favoured uptake of 
pCDE194, albeit in low numbers (Tab.14). 
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Our strains showed different degrees of osmosensitivity. While L. buchneri 
CD034 was able to grow in 0.9 M NaCl, we had to reduce the concentration to 0.7 M 
for L. plantarum CD032 and CD033. The protocol was not suitable for L. lactis 
MG1363, as this strain was even too sensitive to grow in 0.7 M NaCl. 
L. buchneri CD034 was the only strain transformable by the method, 
displaying solid efficiencies. 
 
Table 14. Transformation efficiencies of L. plantarum CD032 and CD033, L. buchneri 
CD034, L. reuteri CD037, and L. lactis MG1363 grown in high salt concentrations 
prior to electroporation (200 Ω/25 µF). n.t. not tested. survival = CFU/aliquot after 
electroporation plated on MRS agar. 
 
Strain 
 
Survival 
Transformants/µg DNA 
pCDWV02 pCD256 pCDE194 pCDWV01 
CD032 (2 kV; 
0.7 M NaCl) 
1 * 10
8 
- -
 
-
 
-
 
CD032 (2.5 kV; 
0.7 M NaCl) 
4 * 10
7 
- - 1 * 10
1
 - 
CD033 (0.7 M 
NaCl) 
n.t. - - - - 
CD034 (0.9 M 
NaCl) 
1 * 10
8
 1 * 10
2 
2 * 10
3
 2 * 10
3 
5 * 10
3 
CD037 (0.4 M 
NaCl) 
7 * 10
6 
- - - - 
CD037 (0.6 M 
NaCl) 
3 * 10
6
 - - - - 
MG1363 (0.7 M 
NaCl) 
- - - - - 
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5. Conclusion 
 
Even if assigned to the same species, strains show huge variation in transformability 
and optimal growth conditions. A protocol working for one strain might not be suitable 
for the other one.  
According to Rossello-Mora et al. (2001), a species is defined as „a 
monophyletic and genomically coherent cluster of individual organisms that show a 
high degree of overall similarity with respect to many independent characteristics, 
and is diagnosable by a discriminative phenotypic property“. Nevertheless many 
characteristics are not shared. It is known for example for probiotics that all health 
benefits and effects are highly strain-specific and not species-specific (Madsen, 
2006). 
In addition to the wide definition of species, the group of lactic acid bacteria 
itself is characterized by a huge heterogeneity, which spreads as far as to strain 
level. Even within our small setting of experiments comparing two strains of 
Lactobacillus plantarum and Lactobacillus buchneri each, the differences were 
astonishingly obvious. Strains differed in as simple characteristics as growth 
dramatically. While L. buchneri CD034 and the L. plantarum strains showed steady 
growth in our experiments, both L. buchneri CD035 and L. reuteri CD037 were 
extremely sensitive. Colonies picked from refrigerated agar plates did not recover in 
fresh liquid medium, which was also true for colonies grown longer than two days 
and taken directly from the incubator. 
On the other hand once the working strains were rendered electrocompetent 
they were in general robust in means of storage and transformability. 
Electrocompetent cells frozen in PEG1500 could be pulsed after thawing without a 
significant decrease in transformation efficiency.  
In accordance to literature, the lithium acetate method affirmed three noteworthy 
phenomena observed before with the initial and high efficiency protocol: 
 
- Two strains of the same species will not imperatively react in the same way to 
the same treatment. This is at first sight obvious for the survival rates and 
transformation efficiencies of L. plantarum CD032 and CD033 as well as for 
the L. buchneri strains CD034 and CD035. 
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- Even differences within a clonal cell suspension are possible as seen for L. 
reuteri CD037 with pCDWV02 and L. lactis MG1363 with pCDWV01. Both 
displayed large and small colonies. The same effect was detected in L. lactis 
MG1363 using the lactococcus high-efficiency protocol. 
 
- The choice of plasmid is crucial. pCDWV01 turned out to be the most effective 
plasmid. This specific plasmid was uniquely characterized by the absence of 
an E. coli origin which might compromise efficient replication in certain 
lactobacilli. 
 
Independent of electroporation protocol or plasmid choice L. reuteri CD037 remained 
reluctant to electroporation. Also the cause and putative reason for agglutinative 
growth of L. reuteri CD037 rests elusive. A mechanism favouring growth of biofilms 
and rendering the strain more robust in the gastrointestinal tract would be possible. 
More probably the strain is subject to a mutation affecting the autolytic process and 
hence complete cell division. As mentioned before such an autolytic deficiency would 
heavily impair permeability of the cell wall and require more aggressive treatments. 
We did not observe such pronounced agglutination in any other working strain. 
The list of possible obstacles to electroporation is manifold, ranging from 
exopolysaccharides and agglutination to more uncommon reasons. For instance, 
Berthier et al. (1996) identified 30 % PEG as a complete inhibitor of 
electrotransformation of L. sake cells which was utilized by default in our 
experiments. PEG is widely used as electroporation or storage solution and was also 
shown to increase electroporation of L. plantarum and a different L. sake strain 
(Bringel and Hubert, 1990; Aukrust and Blom, 1992). Aukrust et al. (1993) described 
loss of electrocompetence of some strains when kept too long on ice before 
electroporation. 
Resident plasmids in the industrial wild-type L. reuteri CD037 also could 
possibly interfere with transforming plasmids and hinder establishment of 
transformants. Transforming plasmids are not equally suitable for all strains 
depending on their size, DNA restriction, modification, and replication mechanism. 
The impact of a huge number of parameters like growth phase, final 
concentration of cells, the choice of plasmids, composition of electroporation solution, 
washing solution, growth media, electroporation conditions like field strength, pulse 
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duration, number of pulses, resistance, and many more aggravate the development 
of a systematic approach to transform recalcitrant strains. It might therefore be more 
promising to conclude the effort on L. reuteri CD037 and to turn towards other 
industrial L. reuteri isolates be it from animal or silage origin. 
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7. Appendix 
 
7.1. Abstract 
 
Lactid acid bacteria are a highly heterogenous group of bacteria used in a variety of 
fields like food and feed fermentation, production of therapeutic proteins, and 
probiotics. Several lactic acid bacteria including strains of L. reuteri have been 
identified as true inhabitants of the gastrointestinal tract of humans, pig, and poultry, 
and are therefore promising candidates in industrial production of pro- and prebiotics.  
 
Genetic engineering is used as a tool to meet industrial needs enabling introduction 
of new characteristics, modulation of gene expression, and more efficient secretion of 
desirable proteins. Electroporation is a common method to introduce foreign genes or 
promotors and is therefore crucial in genetic engineering. A vast number of fast and 
cost-effective electroporation protocols have been developed to allow for 
transformation of different microorganisms. Nevertheless protocols have to be 
optimised for each strain separately. 
 
In this work we evaluated different established electrotransformation protocols for 
their suitability on our working strains belonging to the species L. plantarum, L. 
reuteri, L. buchneri, L. lactis, and E. faecium.  
 
Furthermore we aimed at developing an electrotransformation protocol able to 
penetrate a specific industrial L. reuteri strain.  We tested strategies including 
alterations of growth media, washing solutions, and electrical parameters in addition 
to already published electroporation methods proven to be successful in other L. 
reuteri strains.  
 
Our strains differed highly in transformation efficiencies and optimal growth 
conditions. The chosen electroporation protocols varied in suitability depending on 
the choice of working strain and plasmid. Despite our efforts our L. reuteri strain 
remained reluctant to any transformation protocol which might be due to its 
pronounced agglutination and therefore inaccessible cell wall. 
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7.2. Zusammenfassung 
 
Milchsäurebakterien finden ihre Anwendung in der Nahrungsmittelproduktion, 
Tierfutterfermentation, der Herstellung therapeutischer Proteine und Probiotika. 
Einige Spezies, wie etwa L. reuteri, werden aufgrund ihrer Fähigkeit den 
Gastrointestinaltrakt des Menschen und diverser Tiere zu besiedeln, als Kandidaten 
fuer die industrielle Produktion von Pro- und Präbiotika gehandelt.  
 
Um die Charakteristika einzelner Stämme zu verbessern wird “genetic engineering” 
eingesetzt. Dies umfasst zum Beispiel das Einbringen fremder Gene und den 
Austausch von Promotoren zur kontrollierten Proteinproduktion und –sekretion. Eine 
erfolgreiche Methode hierfür ist die Elektrotransformation, die bereits für eine Vielzahl 
von Mikroorganismen angewendet wird.  Die entsprechenden Protokolle müssen 
allerdings für jeden Stamm individuell optimiert werden. 
 
Im Rahmen dieser Diplomarbeit wurden unterschiedliche 
Elektrotransformationsprotokolle an unseren industriellen Stämmen (L. plantarum, L. 
reuteri, L. buchneri, L. lactis und E. faecium) getestet.  
 
Besonderes Augenmerk wurde auf die Entwicklung eines Transformationsprotokolls 
für einen bestimmten L. reuteri Stamm gelegt. Hierfür wurden die Zusammensetzung 
von Nähr- und Waschlösungen als auch elektrische Parameter variiert. Zusätzlich 
wurden Protokolle getestet, die bereits für andere L. reuteri Stämme erfolgreich 
eingesetzt werden. 
 
Im Laufe der Versuche wurde gezeigt, dass die Wahl des richtigen 
Elektrotransformationsprotokolls entscheidend ist, um optimales Wachstum und 
Transformationseffizienzen zu gewährleisten. Trotz aller Bemühungen konnte der L. 
reuteri Stamm nicht transformiert werden. Dies könnte Folge seines agglutinierenden 
Wachstums und der damit erschwerten Zugänglichkeit der Zellwände sein. 
 
 
 
 
 
 
59 
 
7.3. Curriculum Vitae 
 
 
  
 
 
  
 
 
Europass 
Curriculum Vitae 
 
  
Personal information  
First name(s) / Surname(s)  Natascha Adamovic  
Address Assmayergasse 66/1, 1120 Vienna (Austria) 
Mobile +43676 9203290  
E-mail(s) natascha_adamovic@yahoo.de 
Nationality Austrian  
Date of birth 06 August 1983 
Gender Female  
  
Work experience  
  
Dates 25/08/2011 →  
Occupation or position held Trainee 
Main activities and responsibilities Research on plasma polymerization and antibacterial coatings 
Name and address of employer Ian Wark Research Institute 
Mawson Lakes Campus, 5095 Adelaide (Australia) 
  
Dates 01/02/2011 - 30/06/2011  
Occupation or position held Trainee 
Main activities and responsibilities Training in quality control and documentation in a GMP environment 
Name and address of employer Boehringer Ingelheim RCV 
Dr. Boehringer-Gasse 5-11, 1121 Vienna (Austria) 
  
Dates 01/02/2010 - 31/12/2010  
Occupation or position held Lab technician 
Main activities and responsibilities Cultivation, electroporation and genetic engineering of lactic acid bacteria, 
research for diploma thesis 
Name and address of employer University of Natural Resources and Life Sciences, Institute of Applied 
Microbiology 
Muthgasse 18, 1190 Vienna (Austria) 
  
Dates 12/01/2009 - 31/03/2009  
Occupation or position held Trainee 
Main activities and responsibilities Training in fermentation and development 
Name and address of employer Boehringer Ingelheim RCV 
Dr. Boehringer-Gasse 5-11, 1121 Vienna (Austria) 
  
60 
 
 
Education and training 
 
  
Dates 1/10/2002 - 30/12/2011  
Title of qualification awarded  
Principal subjects / occupational 
skills covered 
University Studies of Genetics, Microbiology, Chemistry and Anthropology 
Name and type of organisation 
providing education and training 
University of Vienna 
Level in national or international 
classification 
 
  
Dates 14/09/2007 - 03/02/2008  
Principal subjects / occupational 
skills covered 
Erasmus in Brussels including internship in a laboratory of the University of 
Brussels 
Focus of research: cancer stem cells 
Name and type of organisation 
providing education and training 
Vrije Universiteit Brussel 
Brussels (Belgium) 
  
Personal skills and 
competences 
 
  
Mother tongue(s) German, Serbian 
  
Other language(s)  
Self-assessment  Understanding Speaking W r i t i n g 
European level (*)  Listening Reading Spoken 
interaction 
Spoken 
production 
 
English  C1  Proficient  
user  
C1  
Proficient 
 user  
C1  
Proficient 
user 
C1  
Proficient 
user 
C1  
Proficient 
user 
French  B1  Independent 
user  
B1  
Independent 
user  
A1  Basic user  A1  Basic user  A1  Basic user  
Italian  B1  Independent 
user  
B1  
Independent 
user 
A2  Basic user  A2  Basic user  A2  Basic user  
Dutch  B1  Independent 
user  
B2  
Independent 
user 
A2  Basic user  A2  Basic user  A1  Basic user  
 (*) Common European Framework of Reference (CEF) level  
  
Social skills and competences Eager to make new experiences, high sense of responsibility, team player, 
stress-resistant and open-minded 
  
Computer skills and competences Good knowledge of Word and PowerPoint 
Basic knowledge of Excel, SPSS, and Adobe Illustrator 
  
Driving licence(s) B  
 
 
